Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
autologous mesenchymal stem cells (1 trial)
bq-a peptide extract (1 trial)
Brain Death (Phase 1)
Brain Injuries (Phase 1)
Brain Injuries, Traumatic (Phase 1)
Death (Phase 1)
Diffuse Axonal Injury (Phase 1)
Trials (1 total)
Trial APIs (2 total)